Connecting the Dots: Diabetes, CKD, and CVD Pathways

Program Information

Connecting the Dots: Diabetes, CKD, and CVD Pathways enhances clinical understanding of the interconnected conditions of type 2 diabetes (T2D), chronic kidney disease (CKD), and cardiovascular disease (CVD). Strengthen recognition of shared pathophysiology, apply evidence-based risk assessment and treatment strategies, and improve care coordination through timely and appropriate referrals to drive better outcomes for patients with complex cardiometabolic conditions.

Learning Objectives

Upon completion of the educational activity, participants should be better able to:  

Explain the complex relationships between insulin resistance and CKD, discuss the underlying mechanisms driving CVD development and progression, and apply a comprehensive framework for risk stratification and prevention of CVD in patients with these comorbidities.

Identify and apply evidence-based risk assessment strategies for CVD in patients with metabolic risk factors, hypertension, diabetes, CKD, or a combination of these, using tools such as risk calculators and biomarkers to facilitate early detection and timely intervention.

Identify guideline-based treatment options for managing CVD in patients with metabolic disease, diabetes, and kidney disease, including lifestyle modifications, emerging and existing pharmacologic interventions such as sodium-glucose cotransporter-2 (SGLT2) inhibitors and glucagon-like peptide-1 receptor agonists (GLP-1), anti-hypertensive therapies, and lipid-lowering agents, and digital health technologies.

Apply clear referral criteria to identify patients requiring specialized care, ensuring timely and appropriate referrals to endocrinologists, cardiologists, nephrologists, and other specialists.

Intended Audience

U.S. healthcare professionals, focusing on primary care professions (PCPs), including physicians, nurse practitioners (NPs), physician assistants (PAs), and specialists such as endocrinologists, cardiologists, and nephrologists who manage patients with T2D, CKD, and CVD.

Faculty

		Mayra Cantazaro, DNP, APRN, FNP-BC, BC-ADM, CDCES Assistant Professor UTRGV-SON: Doctor of Nursing Practice Program Valley Diabetes & Endocrinology Comprehensive Center (VDECC) Edinburg, TX
		Pranjali Sharma, MD, DABOM,FACE, FAPCR, FEAA Endocrinologist Scripps Clinic Division of Diabetes & Endocrinology La Jolla, CA
		Joseph A. Aloi, MD, FACE, FACP Professor Of Medicine Chief Endocrinology & Metabolism Wake Forest University School of Medicine Winston-Salem, NC
		Samina Afreen, MD, FOMA, CCD Endocrinologist University of Virginia Charlottesville, VA

Course Availability

Release Date: 5/12/2025

Expiration Date: 5/12/2026

Summary

Availability:

On-Demand

Cost:

FREE

Credit Offered:

2 CME Credits

2 Nursing Credits

2 ABIM-MOC Points

Recommended

GLP-1 RA’s Role in the Management of Diabetes: Tools for the Primary Care Professional

Starts 10/31/2024 | Expires 10/31/2025

This program aims to equip primary care professionals with the skills to manage type 2 diabetes more effectively, particularly those who may be hesitant to prescribe glucagon-like peptide-1 receptor agonists (GLP-1 RAs).

Multiple Credits

FREE

(15)

Reframing Obesity Treatment: Addressing Stigma, Myths, Misconceptions, and Patient Concerns On-Demand

Multiple Credits

FREE

(11)

Managing TED in Practice: Expanding the Endocrinologist’s Scope

Multiple Credits

FREE

(5)

When Triglycerides Skyrocket: Recognizing and Treating Severe Hypertriglyceridemia

Multiple Credits

FREE

Homozygous Familial Hypercholesterolemia: Prevention of Aggressive Atherosclerosis Requires Aggressive Diagnosis and Treatment

Multiple Credits

FREE

(1)

Paresthesia, Muscle Spasms, and Cramps: Unraveling the Hypocalcemia Puzzle in Hypoparathyroidism

Multiple Credits

FREE

(1)

Kidney in Cardiometabolic Disease - Annual Meeting 2025

The Kidney in Cardiometabolic Disease session presented at the AACE 2025 Annual Meeting highlights the critical role of kidney function in managing cardiometabolic disorders, such as diabetes, heart failure, and cardiovascular diseases, emphasizing the importance of integrated care approaches through a case-based interactive program format.

The session aims to deepen understanding of how renal dysfunction can influence the progression and management of cardiometabolic diseases, with an emphasis on:

• The pathophysiology of chronic kidney disease within the cardiometabolic spectrum, including age-related changes and mineral-bone disorders.
• The impact of renal impairment on cardiovascular risk and metabolic control.
• Strategies for early detection and management of renal complications in cardiometabolic patients, including risk assessment considerations for aging populations with declining renal function

Multiple Credits

FREE

AACE Rare Endocrine Disease Series On Demand: Fatigue, Abnormal Body Composition and Bone Loss: Is Adult GHD to Be Blamed?

Starts 10/28/2024 | Expires 10/28/2025

AACE Rare Endocrine Disease Series is pleased to present Fatigue, Abnormal Body Composition and Bone Loss: Is Adult GHD to Be Blamed? This course is designed to help clinicians create a path to diagnosis when encountering a patient with growth hormone deficiency.

Multiple Credits

FREE

(2)